The number of flu patients in hospital in England has risen by 18%, following a 55% increase the week before. Other UK-wide ...

BI Incorporated, a subsidiary of for-profit prison company GEO Group, will help ICE pinpoint the locations of immigrants.

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

Tezepelumab may allow patients with severe, uncontrolled asthma who are oral corticosteroid-dependent to decrease their OCS use.

AstraZeneca ($AZN) announced an update on their ongoing clinical study. In a recent clinical study update, AstraZeneca has completed a Phase 2a ...